Ligand validation:5IWK

DTB: 6-(5-METHYL-2-OXO-IMIDAZOLIDIN-4-YL)-HEXANOIC ACID

DTB is a Ligand Of Interest in 5IWK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5IWK_DTB_A_702	11%	49%	0.374	0.893	0.71	1.25	-	1	1	0	100%	1
6D7P_DTB_A_703	13%	3%	0.328	0.871	3.11	2.82	3	5	1	0	100%	1
5IWR_DTB_A_705	11%	6%	0.335	0.851	2.78	2.34	5	6	3	0	100%	1
5WO6_DTB_A_702	10%	49%	0.396	0.906	0.71	1.26	-	1	2	0	100%	1
5WO7_DTB_A_701	10%	49%	0.323	0.829	0.71	1.25	-	1	6	0	100%	1
5WO8_DTB_A_701	8%	49%	0.401	0.872	0.7	1.25	-	1	2	0	100%	1
8VCW_DTB_A_405	94%	8%	0.062	0.96	2.11	2.51	2	6	0	0	100%	1
4DNE_DTB_A_201	88%	18%	0.085	0.961	1.89	1.65	3	3	0	0	100%	1
3RDQ_DTB_A_300	86%	20%	0.102	0.97	1.64	1.77	2	3	0	0	100%	1
4A0R_DTB_A_1811	60%	49%	0.183	0.971	0.96	1.01	-	1	2	0	100%	1
8VDW_DTB_B_402	58%	58%	0.164	0.944	0.67	0.94	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.